Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction

Circ J. 2004 Jul;68(7):656-9. doi: 10.1253/circj.68.656.

Abstract

Background: The serum ratio of heart-type fatty acid-binding protein to myoglobin (F/M) has been shown to be a new marker for cardiac damage and volume overload in hemodialysis patients. We evaluated the utility of F/M in hemodialysis patients compared to control subjects.

Methods and results: Twenty-one hemodialysis patients and 17 control subjects with normal renal function were investigated. Using a cutoff point of mean + 2SD of the F/M in the controls (value: 0.147), the hemodialysis patients were divided into 2 groups. The concentrations of atrial natriuretic peptide (ANP) and brain natriuretic peptide after hemodialysis in the high F/M group were higher than those in the low F/M group. The mean level of ANP in the low F/M group was almost the upper limit of normal range. The values of left ventricular end-diastolic dimension and left ventricular mass index in the high F/M group were higher than those in the low F/M group, and the mean levels of those in the low F/M group were almost the same as those in the controls.

Conclusions: The F/M can be evaluated by the absolute value regardless of renal dysfunction, and the value of 0.147 might be useful for determining the cutoff level of cardiac involvement.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Carrier Proteins / blood*
  • Fatty Acid-Binding Proteins
  • Female
  • Heart Diseases / blood
  • Heart Diseases / diagnosis*
  • Heart Diseases / etiology
  • Heart Diseases / physiopathology*
  • Humans
  • Male
  • Middle Aged
  • Myoglobin / blood*
  • Reference Values
  • Renal Dialysis / adverse effects*

Substances

  • Biomarkers
  • Carrier Proteins
  • Fatty Acid-Binding Proteins
  • Myoglobin